Evidence map›Paper›PMID 40636424›Full record

ArticlePlant biotechnology (Tokyo, Japan)2025

Tri-arabinosylation facilitates the bioactivity of CLE3 peptide in

Satoru Nakagami, Taiki Kajiwara, Hajime Hibino, Taku Yoshiya, Masayoshi Mochizuki, Shugo Tsuda, Toshihiro Yamamoto, Shinichiro Sawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plant biotechnology (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Satoru NakagamiGraduate School of Science and Technology, Kumamoto University.
Taiki KajiwaraGraduate School of Science and Technology, Kumamoto University.
Hajime HibinoPeptide Institute, Inc.
Taku YoshiyaPeptide Institute, Inc.
Masayoshi MochizukiPeptide Institute, Inc.
Shugo TsudaPeptide Institute, Inc.
Toshihiro YamamotoPeptide Institute, Inc.
Shinichiro SawaGraduate School of Science and Technology, Kumamoto University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modification is critical for the bioactivity of small secreted-signaling peptides. The shoot apical meristem (SAM) activity that defines SAM size is controlled by the CLAVATA3 (CLV3) peptide ligand, which belongs to the CLV3/EMBRYO SURROUNDING REGIONRELATED (CLE) family, and its cognate receptor CLV1. The mature CLV3 peptide is post-translationally modified with tri-arabinose, increasing the binding affinity with CLV1. However, the mature form of most CLE peptides is unknown. Here we apply the synthetic CLE3 peptide with tri-arabinose to

Indexed as

ArabidopsisCLE peptidepost-translational modificationshoot apical meristem

Identifiers

PMID40636424
PMCPMC12235424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.